Proton Therapy for Primary Renal Cell Carcinoma: The First Nationwide Retrospective Study in Japan

Conclusion: Despite the small number of patients, high-dose PBT can control RCC while maintaining their renal function with high probability, and could be and alternative curative therapy especially for inoperable patients.

Source: In Vivo - August 30, 2020 Category: Research Authors: FUKUMITSU, N., ISHIKAWA, H., ARIMURA, T., WADA, H., OKIMOTO, T., SATO, Y., IWATA, H., SHIMIZU, S., SAKURAI, H. Tags: Clinical Studies Source Type: research